{"name": "Adamis Pharmaceuticals",
 "permalink": "adamis-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/adamis-pharmaceuticals",
 "homepage_url": "http://www.adamispharmaceuticals.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@adamispharma.com",
 "phone_number": "(858) 997-2400",
 "description": "",
 "created_at": "Wed May 29 06:11:38 UTC 2013",
 "updated_at": "Wed May 29 06:31:21 UTC 2013",
 "overview": "\u003Cp\u003EAdamis Pharmaceuticals Corporation is an emerging pharmaceutical company combining specialty pharmaceuticals and biotechnology to provide innovative medicines for patients, physicians and healthcare organizations: Adamis re-defines the Biotech business model by first focusing on profitability through a series of cash crop products. In this way, the traditional pitfalls of Biotech are circumvented, while at the same time, potentially allowing greater shareholder participation through less dilution and self funding. With novel products and breakthrough science, Adamis is poised to become a leader in the biopharmaceutical industry. Our products are concentrated in major therapeutic areas including:\u003C/p\u003E\n\n\u003Cpre\u003E\u003Ccode\u003EAllergy/Respiratory (Asthma/COPD)\nOncology (Cancer)\nImmunology and Infectious Diseases (Viruses)\n\u003C/code\u003E\u003C/pre\u003E\n\n\u003Cp\u003EThe company is currently targeting 5 to 10 product candidates that fit within its niche market strategy. Adamis will strive for regulatory decisions within the United States and look to partner their products throughout the world.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0026/8441/268441v1-max-150x150.png"],
     [[229,
       69],
      "assets/images/resized/0026/8441/268441v1-max-250x250.png"],
     [[229,
       69],
      "assets/images/resized/0026/8441/268441v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$575k",
 "funding_rounds":
  [{"round_code": "debt_round",
    "source_url": "http://www.sec.gov/Archives/edgar/data/887247/000138713113001434/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 575000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 24,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "11455 EL CAMINO REAL",
    "address2": "SUITE 310",
    "zip_code": "92130",
    "city": "SAN DIEGO",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 32.928871,
    "longitude": -117.237734}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        84],
       "assets/images/resized/0026/8440/268440v1-max-150x150.png"],
      [[250,
        140],
       "assets/images/resized/0026/8440/268440v1-max-250x250.png"],
      [[450,
        253],
       "assets/images/resized/0026/8440/268440v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}